sameAs
Investigations on the effectiveness of cefazedone in experimental E. coli pyelonephritisA Pharmacokinetic and Pharmacodynamic Study on Intravenous Cefazedone Sodium in Patients with Community-acquired Pneumonia.Microbiological activity of cefazedone as compared to cefazolin and cephalothin.Investigations on antibacterial activity of cefazedone against Neisseria gonorrhoeae.Bactericidal activity of cefazedone.Antibiotic activity of cefazedone in experimental pyelonephritis.Cross-reactivity in β-Lactam Allergy.Clinical pharmacology phase I of cefazedone, a new cephalosporin, in healthy volunteers. I. Tolerance in comparison with cefazolin.Clinical study on the tolerance of cefazedone.Blood levels and tissue concentrations of cefazedone in animals.Comparison of cefazedone with cefazolin and cephalothin in treatment of experimental infections in mice.In vitro studies with cefazedone.[The diffusion of cefazedone into heart muscle, prostatic and skin tissue and into bile]MIC determination, disc sensitivity testing, and analysis of regression in cefazedone and cefazolinExperimental investigations of the renal tolerance of cefazedoneInvestigations on the action of cefazedone and gentamicin, alone and combined, on renal enzyme excretion in ratsClinical pharmacology phase I of cefazedone, a new cephalosporin, in healthy volunteers. II. Pharmacokinetics in comparison with cefazolinClinical evaluation of cefazedoneDevelopment of an ultra fast liquid chromatography-tandem mass spectrometry method for simultaneous determination of cefazedone and etimicin in beagle dog plasma: Application to the pharmacokinetic study of the combination of cefazedone and etimicin
P921
Q28325152-154FAB7A-018B-48EE-81D9-B921CA51F170Q36797866-5245D1D2-3ABA-4365-86E4-428919834AB9Q39273428-689A1E04-ED52-46BE-95C1-70BA30F82E71Q39687297-9D92E71E-A8AF-497D-865C-02F0F25734F3Q41104387-F32FBCE1-0AE1-40D4-B60F-551ED4E4F23AQ41104393-F17A9E77-1AB9-4ADC-8A99-B8A01FEDE0B7Q41987583-905111C6-15B0-4FFD-A1C5-0CE8AEDA9376Q44036512-5773991C-6194-431F-BFBF-AC039EC6F3A7Q44828753-5F986EBB-AA61-45A1-964A-03DC3720287DQ48113060-962EF8E8-5218-434E-989F-1AA06E9A46BCQ50222181-2AB5ECBC-C2D6-4F1E-939F-DCB7DCD5184FQ54574490-50AC7BFA-805B-4103-9167-EF61FC401E3DQ67002839-47A16EF2-2F7F-43B6-A9A8-07EF0924604FQ67029235-D4519AEF-BDC7-468B-9C3E-3DE332EBF559Q67029240-1D362B83-652F-4E2C-9EBB-D287A68EFB5CQ67029242-0B1A9191-11C1-4070-8FCF-CC550E3897D2Q67029245-ABC22C4A-F5BB-4C71-B83E-B496E433B072Q67029250-2B9421E8-F434-4E98-967F-439405C3FCA2Q86162354-EAD34DEA-6557-4F79-B364-19896B1996AD
P921
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Cefazedon
@de
Cefazedon
@sh
Cefazedon
@sr
Cefazedone
@vi
cefazedone
@en
سفازدون
@fa
سيفازيدون
@ar
เซฟาซีโดน
@th
type
label
Cefazedon
@de
Cefazedon
@sh
Cefazedon
@sr
Cefazedone
@vi
cefazedone
@en
سفازدون
@fa
سيفازيدون
@ar
เซฟาซีโดน
@th
altLabel
Cefazedone
@ar
EMD-30087
@en
السيفازيدون
@ar
prefLabel
Cefazedon
@de
Cefazedon
@sh
Cefazedon
@sr
Cefazedone
@vi
cefazedone
@en
سفازدون
@fa
سيفازيدون
@ar
เซฟาซีโดน
@th
P486
P592
P6366
P661
P662
P665
P683
P117
P1579
P2017
CC1=NN=C(S1)SCC2=C(N3[C@@H]([C@@H](C3=O)NC(=O)CN4C=C(C(=O)C(=C4)Cl)Cl)SC2)C(=O)O
P2067
P2275
cefazedone
@en
P231
56187-47-4
P232
P233
CC1=NN=C(S1)SCC2=C(N3C(C(C3=O)NC(=O)CN4C=C(C(=O)C(=C4)Cl)Cl)SC2)C(=O)O
P234
1S/C18H15Cl2N5O5S3/c1-7-22-23- ...... 21,26)(H,29,30)/t12-,16-/m1/s1
P235
VTLCNEGVSVJLDN-MLGOLLRUSA-N
P2566
100.121.805